Publication | Open Access
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
5.4K
Citations
29
References
2005
Year
Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1